title: [IMRT and head and neck tumors: does differential fractionation have a role?].
abstract: For head and neck cancer, intensity-modulated radiation therapy (IMRT) provides benefits in terms of coverage of the target tumour volume and reduction of the dose to organs at risk. Altered fractionation called SMART (simultaneous modulated accelerated radiation therapy) or SIB (simultaneous integrated boost), equivalent to the "concomitant boost" of conventional techniques, provides additional theoretical gain in the therapeutic index and simplifies the practical implementation of the treatment. The impact on tumour control and acute and late toxicities is encouraging but needs to be confirmed by prospective clinical studies with sufficient follow-up. A lot of different protocols have been tested without really bringing out a "gold standard". However, the current results tend to suggest a SIB/SMART-IMRT moderately accelerated without combined chemotherapy for limited stages (I and II), and SIB-IMRT slightly accelerated with induction and/or concomitant chemotherapy for more advanced stages (III and IV).
authors: Service d'oncologie-radiothérapie, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, Sorbonne Paris-Cité , 75015 Paris, France. Electronic address: philippe.giraud@egp.aphp.fr.
authors: P
authors: P
authors: Giraud
authors: S
authors: S
authors: Servagi-Vernat
mesh_terms: D019583:Dose Fractionation, Radiation; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*
keywords: Altered fractionation; Boost concomitant; Cancer de la tête et du cou; Concomitant boost; Head and neck carcinoma; IMRT; Modification du fractionnement; Radiothérapie avec modulation d’intensité